Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > BSEcho 2024 📅 Friday 11 + Saturday 12 October 2024
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Comment by jopatcloon Aug 16, 2024 10:10am
50 Views
Post# 36182406

RE:RE: BSEcho 2024 📅 Friday 11 + Saturday 12 October 2024

RE:RE: BSEcho 2024 📅 Friday 11 + Saturday 12 October 2024Remember on PHD study using Ventripoint - Dario Freitas
If you’re at BCCA, come and see our stand to find out more about this exciting technology (and my new job!)
This week at the British Congenital Cardiac Association, we caught up with Dario Freitas, Clinical Scientist assessing RV volumes and functions using the Ventripoint system.
 
Loaded: 100.00%
 
 
Remaining time 0:53
 
 
PHD study using Ventripoint - Dario Freitas
jopatclo wrote:
Darios profile photo
Dario Freitas likes this
We're delighted to welcome Dr Victoria Delgado to BSEcho2024 and we're excited to hear her perspective on the role of AI in echo, including how it will impact clinical practice

Catch her in person or online at BSEcho 2024 - register here: https://ow.ly/UpXF50SN0A1



If you’re at BCCA, come and see our stand to find out more about this exciting technology (and my new job!)
This week at the British Congenital Cardiac Association, we caught up with Dario Freitas, Clinical Scientist assessing RV volumes and functions using the Ventripoint system.
 
Loaded: 100.00%
 
 
Remaining time 0:53
 
 
PHD study using Ventripoint - Dario Freitas

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities